Recombinant Human PRPS1 His-tag Protein, CF

R&D Systems | Catalog # 11075-PS

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human PRPS1 His-tag Protein (11075-PS)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

P60891.2

Applications

Enzyme Activity
View all PRPS1 Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human PRPS1 protein
Pro2-Leu318 with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Pro2

Predicted Molecular Mass

36 kDa

SDS-PAGE

36 kDa

Activity

Measured by its ability to convert D-ribose 5-phosphate to 5-phospho-alpha-D-ribose.
The specific activity is >25 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human PRPS1 His-tag Protein, CF

Recombinant Human PRPS1 His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human PRPS1 His-tag Protein (Catalog # 11075-PS) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 36 kDa.

Formulation, Preparation, and Storage

11075-PS
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, Glycerol and TCEP.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: PRPS1

Ribose-phosphate pyrophosphokinase 1 (PRPS1), also known as phosphoribosyl pyrophosphate synthase I, is a highly conserved, ubiquitously expressed enzyme from the ribose-phosphate pyrophosphokinase family that catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) from adenosine triphosphate (ATP) and ribose-5-phosphate (R5P). It is a crucial enzyme in the de novo synthesis and salvage of purines and biosynthesis of pyrimidine and pyrimidine nucleotides (1, 2). PRPS1 is activated by inorganic phosphate and magnesium and can be allosterically inhibited by ADP and purines (2, 3). Human PRPS1 is a 318 amino acid monomer that forms an active hexamer consisting of three homodimers arranged in a propellar-like shape (4). Each homodimer has an active site that binds both ATP and R5P as well as an allosteric inhibitor site. It has been well-established that many different mutations in the PRPS1 gene can lead to disease. Mutations can result in a gain of function with increased expression that leads to excess purine production present in PRS-I superactivity characterized by gout, hearing loss, hypotonia, and ataxia (2, 5). Alternatively, mutations can result in loss of function with decreased expression present in nonsyndromic sensorineural deafness (DFN-2), Charcot-Marie-Tooth disease-5 (CMTX5), and Arts syndrome characterized by sensorineural hearing loss, optic atrophy, ataxia, neuropathy motor development delay and intellectual disability (2,5,6). Mis-regulation of expression and mutation of PRPS1 expression has also been shown to promote proliferation in cancers including neuroblastoma (7), squamous cell carcinoma (8), and acute lymphoblastic leukaemia (9). Additionally, PRPS1 has been shown to be regulated through its phosphorylation state to play a role in DNA repair in the innate immune response (10) and promote tumorigenesis (11).

References

  1. Taira, M. et al. (1989) Biochim. Biophys. Acta. 1007:203.
  2. Mittal, R. et al. (2015) Dis. Markers. 2015:127013.
  3. Nosal, J.M. et al. (1993) J. Biol. Chem. 268:10168.
  4. Sheng, L.I. et al. (2007) Biochem. J. 401:39.
  5. De Brouwer, A.P. et al. (2010) Am. J. Hum. Genet. 86:506.
  6. Mercati, O. et al. (2020) Eur. J. Med. Genet. 63:104033.
  7. Li, J. et al. (2019) Cells. 8:955.
  8. Yang, J. et al. (2021) Arab. J. Gastroenterol. 22:40.
  9. Somazu, S. et al. (2021) J. Cell. Mol. Med. 25:10521.
  10. Liu, R. et al. (2021) Cell Metab. 33:2076.
  11. Jing, X. et al. (2019) Cancer Res. 79:4650.

Long Name

Phosphoribosyl Pyrophosphate Synthetase 1

Alternate Names

CMTX5, DFN2, DFNX1, PPRibP, PRS I, PRS-I, PRSI

Entrez Gene IDs

5631 (Human)

Gene Symbol

PRPS1

UniProt

P60891.2

Additional PRPS1 Products

Product Documents for Recombinant Human PRPS1 His-tag Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human PRPS1 His-tag Protein, CF

For research use only

Customer Reviews for Recombinant Human PRPS1 His-tag Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human PRPS1 His-tag Protein, CF and earn rewards!

Have you used Recombinant Human PRPS1 His-tag Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human PRPS1 His-tag Protein, CF (11075-PS):

Materials
  • Assay Buffer:  50 mM Tris, 10 mM MgCl2, pH 7.5
  • Recombinant Human Phosphoribosyl Pyrophosphate Synthetase 1 (rhPRPS-1) (Catalog # 11075-PS)
  • D-Ribose 5-phosphate disodium salt hydrate (R5P) (Sigma, Catalog # R7750), 150 mM stock in deionized water
  • Adenosine triphosphate (ATP) (Sigma, Catalog # A7699), 10 mM stock in deionized water
  • Recombinant Human 5'-Nucleotidase/CD73 (rhCD73) (Catalog # 5795-EN)
  • Malachite Green Phosphate Detection Kit (Catalog # DY996)
  • 96-well Clear Plate (Catalog # DY990)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Prepare a standard curve from the 1 M Phosphate Standard by adding 10 µL of the 1 M Phosphate Standard to 990 µL of Assay Buffer for a 10 mM stock. Continue by adding 10 µL of the 10 mM Phosphate stock to 990 µL of Assay Buffer for a 100 µM stock (this is the first dilution to use as a standard).
  2. Perform six additional one-half serial dilutions of the 100 µM Phosphate stock using Assay Buffer. The standard curve has a range of 0.078 to 5 nmol per well.
  3. Prepare Reaction Mixture containing 400 µM ATP, 1 mM R5P and 0.6 µg/mL rhCD73 in Assay Buffer.
  4. Dilute rhPRPS-1 to 80 µg/mL in Assay Buffer.
  5. Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 μL of Assay Buffer.
  6. Load 25 µL of 80 µg/mL rhPRPS-1 into empty wells of the same plate as the curve. Include a Control containing 25 μL of Assay Buffer.
  7. Start the reactions by adding 25 µL of Reaction Mixture to all wells, excluding the standard curve and curve blank.  
  8. Seal plate and incubate at room temperature for 20 minutes.
  9. Add 30 µL of the Malachite Green Reagent A to all wells used, including standard curve. Mix briefly.
  10. Add 100 µL of deionized water to all wells used, including standard curve. Mix briefly.
  11. Add 30 µL of the Malachite Green Reagent B to all wells used, including standard curve. Mix briefly.
  12. Seal plate and incubate at room temperature for 20 minutes.
  13. Read plate at 620 nm (absorbance) in endpoint mode.
  14. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

 Phosphate released* (nmol) x (1000 pmol/nmol)
Incubation time (min) x amount of enzyme (µg)

     *Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control.

Per Reaction:

  • rhPRPS-1: 2 µg
  • rhCD73: 0.015 µg
  • ATP: 200 µM
  • R5P: 500 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes